As many as 100,000 cases of cancer could be prevented in the U.S. each year if Americans get rid of their excess body fat.
That’s according to estimates released by the American Institute for Cancer Research. The estimates suggest that heart disease, diabetes, and joint problems aren’t the only illnesses in which rampant obesity is causing havoc.
The group says overweight and obesity could be the cause of more than 6% of all the estimated 1.6 million cancer cases diagnosed in the U.S. each year. Read the rest of this entry »
Posted by admin | Posted in Cancer | Posted on 09-11-2009
An article published Online First and in a future edition of The Lancet reports that prevention or delay of type 2 diabetes with lifestyle intervention or metformin can persist for at least ten years. The article is the work of Dr. William C. Knowler of the U.S. National Institute of Diabetes and Digestive and Kidney Diseases and colleagues from the Diabetes Prevention Program Research Group.
The Diabetes Prevention Program (DPP) randomised clinical trial took place for 2.8 years. During this time, diabetes incidence in high-risk adults was reduced by 58 percent with intensive lifestyle intervention and by 31 percent with metformin, compared with placebo. The Diabetes Prevention Program Outcomes Study is a long-term follow-up study. The authors investigated the persistence of these lasting effects. Read the rest of this entry »
Daytime sleepiness caused by the nighttime breathing disorder sleep apnea is nothing to yawn at.
A new study from Canada hints that the risk of diabetes may be two to three times higher among people with severe sleep apnea who also suffer daytime sleepiness.
“This raises the intriguing possibility that sleepiness (or sleep disruption) may have an independent effect on the risk for diabetes,” Dr. Willis H. Tsai, of Rockview General Hospital in Calgary, Alberta, noted in an email to Reuters Health. Read the rest of this entry »
A new study has found a combination of insulin and vitamin C may stop the damage caused by type 1 diabetes.
Scientists from at the Harold Hamm Oklahoma Diabetes Center found that this particular combination stopped blood vessel damage, known as endothelial dysfunction, caused by the disease in patients with poor glucose control.
“We had tested this theory on research models, but this is the first time anyone has shown the therapy’s effectiveness in people,” explains Dr. Michael Ihnat, principal investigator and a pharmacologist at the OU College of Medicine Department of Cell Biology. Read the rest of this entry »
New research suggests flaxseed may help improve cholesterol.
A study appearing in the American Journal of Clinical Nutrition finds people who took one tablespoon of whole flaxseed everyday were able to reduce both their total cholesterol and their LDL, or bad, cholesterol levels. Flaxseed oil, in comparison, did not produce the same results.
Women, particularly post-menopausal women, had the greatest reduction in their cholesterol, compared to men and other people who previously had higher cholesterol levels, according to Reuters. Read the rest of this entry »
Adding the common diabetes drug metformin to chemotherapy helped shrink breast cancer tumors faster in mice and keep them away longer than chemotherapy alone, raising hope for a more effective way to treat cancer, U.S. researchers said on Monday.
They said metformin appeared to target breast cancer stem cells — a kind of master cancer cell that resists conventional treatment and may be the source of many tumors that grow back.
“What’s exciting here is we now have something that is mechanistically a different kind of killer of cancer that can synergize with chemotherapy,” Kevin Struhl of Harvard Medical School, whose study appears in the journal Cancer Research, said in a telephone briefing. Read the rest of this entry »
Posted by admin | Posted in Cancer | Posted on 14-09-2009
